Mark McLeod

Mark McLeod is a Researcher at Dalhousie University, affiliated with the Novel Tech Ethics research group. He is also a practicing Barrister & Solicitor in Nova Scotia and Ontario, as well as a registered Trade-mark Agent with CIPO and USPTO.

Education

• Ph.D. in Pharmaceutical Sciences (University of Melbourne, Australia)
• J.D. (Juris Doctor) from Melbourne Law School (University of Melbourne, Australia)

Research Interests

Dr. McLeod’s research focuses on Stem Cell Research and Neuropharmacology, particularly related to Neurological Disorders like Parkinson’s disease, Huntington’s disease, and schizophrenia. His work bridges scientific and Biomedical Ethics considerations, including Legal Ethics and Health Law frameworks for translating stem cell research to clinical applications.

Professional Background

He co-founded the intellectual property law firm Abaunza McLeod LLP, with offices in Nova Scotia and Ontario, and provides critical legal analysis to Dalhousie’s Novel Tech Ethics. His postdoctoral work at the Brain Repair Centre in Halifax focused on stem cell differentiation for neural transplantation.